TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,673 | -99.1% | 70,870 | +1537.5% | 0.00% | – |
Q2 2021 | $311,000 | -76.0% | 4,328 | -81.7% | 0.00% | -100.0% |
Q3 2020 | $1,295,000 | -51.5% | 23,607 | -41.3% | 0.00% | -60.0% |
Q2 2020 | $2,672,000 | +990.6% | 40,190 | +904.8% | 0.01% | +400.0% |
Q1 2020 | $245,000 | -94.9% | 4,000 | -92.7% | 0.00% | -90.9% |
Q4 2019 | $4,793,000 | -53.9% | 54,506 | -60.5% | 0.01% | -54.2% |
Q3 2019 | $10,404,000 | -19.8% | 137,899 | -9.2% | 0.02% | -17.2% |
Q2 2019 | $12,974,000 | -28.1% | 151,879 | -9.0% | 0.03% | -32.6% |
Q1 2019 | $18,045,000 | +11.5% | 166,942 | -12.7% | 0.04% | +2.4% |
Q4 2018 | $16,184,000 | -20.3% | 191,208 | -7.4% | 0.04% | -8.7% |
Q3 2018 | $20,304,000 | -16.9% | 206,547 | -2.2% | 0.05% | -23.3% |
Q2 2018 | $24,439,000 | +848.7% | 211,247 | +709.7% | 0.06% | +900.0% |
Q1 2018 | $2,576,000 | -76.8% | 26,091 | -75.4% | 0.01% | -77.8% |
Q4 2017 | $11,093,000 | – | 105,941 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |